Recursion Pharmaceuticals, Inc.

RXRX

RXRXRecursion Pharmaceuticals, Inc. US flag

NASDAQ Global Select

3.80

USD

+0.33

- -

1.70BMarket Cap

Profitability (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-43.5	-41.03	-36.52	-48.42	-44.11	-44.12
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	-21.66	2.94	22.65	4.45
EBITDA Margin (%)	-3,503.92	-2,363.67	-1,743.7	-589.63	-742.22	-756.58	-760.12
Operating Margin (%)	-3,649.39	-2,479.2	-1,827.75	-619.26	-797.84	-818.98	-872.83
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-3,616.54	-2,549.25	-1,864.79	-603.5	-756.97	-794.67	-868.48
Profit Margin (%)	-3,616.54	-2,549.25	-1,864.79	-603.5	-747.71	-792.75	-868.29
Net Income to Common Margin (%)	-3,616.54	-2,549.25	-1,864.79	-603.5	-747.71	-792.75	-868.29
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	16	16	11	51	51	108	78
ST Debt	1	2	2	6	6	22	22
LT Debt	16	14	10	45	45	86	56
Total Debt/EBITDA	-0.27	-0.19	-0.07	-0.22	-0.16	-0.25	-0.14
Net Debt/EBITDA	0.96	3.09	1.63	2.35	1.2	1.28	1.28
Total Debt/EBIT	-0.26	-0.19	-0.06	-0.21	-0.14	-0.23	-0.12
Net Debt/EBIT	0.92	2.95	1.56	2.24	1.12	1.18	1.12
EBITDA to Interest Expense	-94.41	-59.32	-59.07	-4,254.02	-3,357.3	-281.49	-311.84
EBITDA-CapEx/Interest Expense	-100.57	-64.27	-72.55	-4,933.27	-3,486.7	-292.34	-316.61
EBIT to Interest Expense	-98.33	-62.22	-61.92	-4,467.76	-3,608.87	-304.71	-358.08
Interest Expense	1	1	3	- -	- -	2	2
Common Equity/Total Assets	-124.81	-71.54	-65.55	-91.2	-148.02	-98.8	-140.83
Long-Term Debt/Equity (%)	- -	- -	1.84	9.25	9.61	8.34	4.97
Long-Term Debt/Capital (%)	-14.15	-7.13	-2.57	-7.64	-4.85	-6.52	-2.81
Long-Term Debt/Total Assets (%)	15.4	4.73	1.63	6.41	6.81	5.96	3.81
Total Debt/Equity (%)	-13.01	-7.59	2.11	10.5	10.93	10.48	6.89
Total Debt/Capital (%)	-14.64	-7.91	-2.95	-8.67	-5.53	-8.2	-3.9
Total Debt/Total Assets (%)	15.94	5.25	1.88	7.27	7.75	7.49	5.29
Net Debt to Equity	46.18	121.01	-52.38	-113.07	-84.25	-54.78	-64.08
Net Debt/Capital (%)	31.83	54.26	42.21	48.25	29.84	29.57	26.43
EBITDA	-60	-81	-174	-234	-326	-443	-564
EBITDA-CapEx	-64	-87	-214	-271	-338	-460	-573
Operating Income (Loss)	-62	-85	-183	-246	-350	-479	-648

Liquidity (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	10.46	11.35	11.07	5.48	4.2	3.17	5.03
Current Ratio	11.43	11.53	11.46	5.68	4.7	3.81	5.5
Quick Ratio	10.48	11.35	11.27	5.51	4.24	3.43	5.2
CFO/Avg Current Liab	- -	-3.05	-4.55	-1.14	-2.98	-2.56	-2.22
Common Equity/Total Assets	-124.81	-71.54	-65.55	-91.2	-148.02	-98.8	-140.83
Long-Term Debt/Equity (%)	- -	- -	1.84	9.25	9.61	8.34	4.97
Long-Term Debt/Capital (%)	-14.15	-7.13	-2.57	-7.64	-4.85	-6.52	-2.81
Long-Term Debt/Total Assets (%)	15.4	4.73	1.63	6.41	6.81	5.96	3.81
Total Debt/Equity (%)	-13.01	-7.59	2.11	10.5	10.93	10.48	6.89
Total Debt/Capital (%)	-14.64	-7.91	-2.95	-8.67	-5.53	-8.2	-3.9
Total Debt/Total Assets (%)	15.94	5.25	1.88	7.27	7.75	7.49	5.29
CFO/Total Liabilities	-25.27	-8.99	-235.31	-38.76	-151.25	-86.8	-108.32
CFO/CapEx	-14.59	-6.74	-3.99	-2.24	-22.93	-21.07	-43.1
Altman's Z-Score	-2.94	-0.96	18.18	2.19	2.83	-0.31	-0.97

Working Capital (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	22.23	105.26	2,334.18	- -	- -	- -
Days Sales Outstanding	- -	16.42	3.47	0.16	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	13.04	9.97	3.54	3.57
Accounts Payable Turnover Days	- -	- -	- -	27.99	36.59	103.14	102.19
Cash Conversion Cycle	- -	- -	- -	-27.84	-36.59	-103.14	-102.19
Inventory to Cash Days	- -	- -	- -	0.16	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	2,147	1,353	2,049	1,854	1,830
- Cash & Cash Equivalents	70	262	285	550	392	594	743
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	16	16	11	51	51	108	78
Enterprise Value	-54	-246	1,642	854	1,709	1,368	1,165
Total Capital	-110	-198	-389	-589	-917	-1,323	-1,998
Total Debt/Capital (%)	-14.64	-7.91	-2.95	-8.67	-5.53	-8.2	-3.9
Total Debt / EV	-0.3	-0.06	0.01	0.06	0.03	0.08	0.07
EV/Sales	- -	- -	164.21	21.53	38.94	23.39	15.69
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	2,147	1,353	2,049	1,854	1,830
Diluted Enterprise Value	-54	-246	1,874	854	1,709	1,368	1,165
EV per Share	- -	- -	13.1	4.87	8.22	4.99	2.6
TTM Sales	2	3	10	40	44	58	74
TTM EBITDA	-60	-81	-174	-234	-326	-443	-564
TTM Operating Income	-62	-85	-183	-246	-350	-479	-648
TTM Cash Flow to Firm	-56	-44	-156	-83	-288	-358	-370
TTM Free Cash Flow to Firm	-52	-37	-116	-46	-275	-341	-361

Multiples (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-18.07	-29.32	-7.45	-5.42	-5.04
EV/EBIT	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-54	-246	1,642	854	1,709	1,368	1,165
Low Price	- -	- -	15.25	4.92	4.54	5.6	3.79
EV/Sales	- -	- -	164.21	21.53	38.94	23.39	15.69
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-17.01	-6.83	-5.08	-4.97	-3.87
Price/Earnings High	- -	- -	-28.78	-13.36	-10.61	-9.31	-8.58
Price/Earnings Low	- -	- -	-10.25	-3.61	-2.88	-3.31	-2.63
Price/Book Value	- -	- -	-5.37	-2.12	-2.12	-1.3	-0.88
Price/Book Value Average	- -	- -	-7.93	-2.56	-1.72	-1.61	-1.2
Price/Book Value High	- -	- -	-13.41	-5	-3.6	-3.02	-2.66
Price/Book Value Low	- -	- -	-4.78	-1.35	-0.98	-1.07	-0.82
Price/Tangible Book Value	- -	- -	3.97	2.8	5.47	3.37	2.78
Price/Tangible Book Value Average	- -	- -	5.86	3.38	4.44	4.19	3.79
Price/Tangible Book Value High	- -	- -	9.92	6.62	9.28	7.85	8.39
Price/Tangible Book Value Low	- -	- -	3.54	1.79	2.52	2.79	2.57
Price/Sales	- -	- -	214.72	34.11	46.71	31.69	24.65
Price/Sales Average	- -	- -	317.13	41.24	37.96	39.4	33.63
Price/Sales High	- -	- -	536.62	80.64	79.33	73.79	74.48
Price/Sales Low	- -	- -	191.16	21.76	21.51	26.25	22.84
Price/Cash Flow	- -	- -	-13.54	-16.2	-7.12	-5.16	-4.92
Price/Cash Flow Average	- -	- -	-19.99	-19.59	-5.79	-6.42	-6.72
Price/Cash Flow High	- -	- -	-33.83	-38.31	-12.09	-12.02	-14.87
Price/Cash Flow Low	- -	- -	-12.05	-10.34	-3.28	-4.28	-4.56
Price/Free Cash Flow Average	- -	- -	-26.69	-35.44	-6.05	-6.74	-6.88
Price/Free Cash Flow High	- -	- -	-45.16	-69.32	-12.65	-12.62	-15.23
Price/Free Cash Flow Low	- -	- -	-16.09	-18.71	-3.43	-4.49	-4.67
EV/Sales Average	- -	- -	289.77	28.66	30.19	31.09	24.67
EV/Sales High	- -	- -	509.25	68.07	71.56	65.49	65.52
EV/Sales Low	- -	- -	163.79	9.19	13.74	17.95	13.88
EV/EBITDA Average	0.9	3.06	-16.62	-4.86	-4.07	-4.11	-3.24
EV/EBITDA High	0.9	3.06	-29.21	-11.54	-9.64	-8.66	-8.62
EV/EBITDA Low	0.9	3.06	-9.39	-1.56	-1.85	-2.37	-1.83
EV/EBIT Average	0.86	2.91	-15.85	-4.63	-3.78	-3.8	-2.83
EV/EBIT High	0.86	2.91	-27.86	-10.99	-8.97	-8	-7.51
EV/EBIT Low	0.86	2.91	-8.96	-1.48	-1.72	-2.19	-1.59
Last Price	- -	- -	17.13	7.71	9.86	6.76	4.09
High Price	- -	- -	42.81	18.23	16.74	15.74	12.36
Enterprise Value Average	-54	-246	2,898	1,137	1,325	1,819	1,832
Enterprise Value High	-54	-246	5,093	2,701	3,140	3,830	4,865
Enterprise Value Low	-54	-246	1,638	365	603	1,050	1,030

Profitability (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-43.5	-41.03	-36.52	-48.42	-44.11	-44.12
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	-21.66	2.94	22.65	4.45
EBITDA Margin (%)	-3,503.92	-2,363.67	-1,743.7	-589.63	-742.22	-756.58	-760.12
Operating Margin (%)	-3,649.39	-2,479.2	-1,827.75	-619.26	-797.84	-818.98	-872.83
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-3,616.54	-2,549.25	-1,864.79	-603.5	-756.97	-794.67	-868.48
Profit Margin (%)	-3,616.54	-2,549.25	-1,864.79	-603.5	-747.71	-792.75	-868.29
Net Income to Common Margin (%)	-3,616.54	-2,549.25	-1,864.79	-603.5	-747.71	-792.75	-868.29
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	16	16	11	51	51	108	78
ST Debt	1	2	2	6	6	22	22
LT Debt	16	14	10	45	45	86	56
Total Debt/EBITDA	-0.27	-0.19	-0.07	-0.22	-0.16	-0.25	-0.14
Net Debt/EBITDA	0.96	3.09	1.63	2.35	1.2	1.28	1.28
Total Debt/EBIT	-0.26	-0.19	-0.06	-0.21	-0.14	-0.23	-0.12
Net Debt/EBIT	0.92	2.95	1.56	2.24	1.12	1.18	1.12
EBITDA to Interest Expense	-94.41	-59.32	-59.07	-4,254.02	-3,357.3	-281.49	-311.84
EBITDA-CapEx/Interest Expense	-100.57	-64.27	-72.55	-4,933.27	-3,486.7	-292.34	-316.61
EBIT to Interest Expense	-98.33	-62.22	-61.92	-4,467.76	-3,608.87	-304.71	-358.08
Interest Expense	1	1	3	- -	- -	2	2
Common Equity/Total Assets	-124.81	-71.54	-65.55	-91.2	-148.02	-98.8	-140.83
Long-Term Debt/Equity (%)	- -	- -	1.84	9.25	9.61	8.34	4.97
Long-Term Debt/Capital (%)	-14.15	-7.13	-2.57	-7.64	-4.85	-6.52	-2.81
Long-Term Debt/Total Assets (%)	15.4	4.73	1.63	6.41	6.81	5.96	3.81
Total Debt/Equity (%)	-13.01	-7.59	2.11	10.5	10.93	10.48	6.89
Total Debt/Capital (%)	-14.64	-7.91	-2.95	-8.67	-5.53	-8.2	-3.9
Total Debt/Total Assets (%)	15.94	5.25	1.88	7.27	7.75	7.49	5.29
Net Debt to Equity	46.18	121.01	-52.38	-113.07	-84.25	-54.78	-64.08
Net Debt/Capital (%)	31.83	54.26	42.21	48.25	29.84	29.57	26.43
EBITDA	-60	-81	-174	-234	-326	-443	-564
EBITDA-CapEx	-64	-87	-214	-271	-338	-460	-573
Operating Income (Loss)	-62	-85	-183	-246	-350	-479	-648

Liquidity (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	10.46	11.35	11.07	5.48	4.2	3.17	5.03
Current Ratio	11.43	11.53	11.46	5.68	4.7	3.81	5.5
Quick Ratio	10.48	11.35	11.27	5.51	4.24	3.43	5.2
CFO/Avg Current Liab	- -	-3.05	-4.55	-1.14	-2.98	-2.56	-2.22
Common Equity/Total Assets	-124.81	-71.54	-65.55	-91.2	-148.02	-98.8	-140.83
Long-Term Debt/Equity (%)	- -	- -	1.84	9.25	9.61	8.34	4.97
Long-Term Debt/Capital (%)	-14.15	-7.13	-2.57	-7.64	-4.85	-6.52	-2.81
Long-Term Debt/Total Assets (%)	15.4	4.73	1.63	6.41	6.81	5.96	3.81
Total Debt/Equity (%)	-13.01	-7.59	2.11	10.5	10.93	10.48	6.89
Total Debt/Capital (%)	-14.64	-7.91	-2.95	-8.67	-5.53	-8.2	-3.9
Total Debt/Total Assets (%)	15.94	5.25	1.88	7.27	7.75	7.49	5.29
CFO/Total Liabilities	-25.27	-8.99	-235.31	-38.76	-151.25	-86.8	-108.32
CFO/CapEx	-14.59	-6.74	-3.99	-2.24	-22.93	-21.07	-43.1
Altman's Z-Score	-2.94	-0.96	18.18	2.19	2.83	-0.31	-0.97

Working Capital (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	22.23	105.26	2,334.18	- -	- -	- -
Days Sales Outstanding	- -	16.42	3.47	0.16	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	13.04	9.97	3.54	3.57
Accounts Payable Turnover Days	- -	- -	- -	27.99	36.59	103.14	102.19
Cash Conversion Cycle	- -	- -	- -	-27.84	-36.59	-103.14	-102.19
Inventory to Cash Days	- -	- -	- -	0.16	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	2,147	1,353	2,049	1,854	1,830
- Cash & Cash Equivalents	70	262	285	550	392	594	743
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	16	16	11	51	51	108	78
Enterprise Value	-54	-246	1,642	854	1,709	1,368	1,165
Total Capital	-110	-198	-389	-589	-917	-1,323	-1,998
Total Debt/Capital (%)	-14.64	-7.91	-2.95	-8.67	-5.53	-8.2	-3.9
Total Debt / EV	-0.3	-0.06	0.01	0.06	0.03	0.08	0.07
EV/Sales	- -	- -	164.21	21.53	38.94	23.39	15.69
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	2,147	1,353	2,049	1,854	1,830
Diluted Enterprise Value	-54	-246	1,874	854	1,709	1,368	1,165
EV per Share	- -	- -	13.1	4.87	8.22	4.99	2.6
TTM Sales	2	3	10	40	44	58	74
TTM EBITDA	-60	-81	-174	-234	-326	-443	-564
TTM Operating Income	-62	-85	-183	-246	-350	-479	-648
TTM Cash Flow to Firm	-56	-44	-156	-83	-288	-358	-370
TTM Free Cash Flow to Firm	-52	-37	-116	-46	-275	-341	-361

Multiples (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-18.07	-29.32	-7.45	-5.42	-5.04
EV/EBIT	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-54	-246	1,642	854	1,709	1,368	1,165
Low Price	- -	- -	15.25	4.92	4.54	5.6	3.79
EV/Sales	- -	- -	164.21	21.53	38.94	23.39	15.69
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-17.01	-6.83	-5.08	-4.97	-3.87
Price/Earnings High	- -	- -	-28.78	-13.36	-10.61	-9.31	-8.58
Price/Earnings Low	- -	- -	-10.25	-3.61	-2.88	-3.31	-2.63
Price/Book Value	- -	- -	-5.37	-2.12	-2.12	-1.3	-0.88
Price/Book Value Average	- -	- -	-7.93	-2.56	-1.72	-1.61	-1.2
Price/Book Value High	- -	- -	-13.41	-5	-3.6	-3.02	-2.66
Price/Book Value Low	- -	- -	-4.78	-1.35	-0.98	-1.07	-0.82
Price/Tangible Book Value	- -	- -	3.97	2.8	5.47	3.37	2.78
Price/Tangible Book Value Average	- -	- -	5.86	3.38	4.44	4.19	3.79
Price/Tangible Book Value High	- -	- -	9.92	6.62	9.28	7.85	8.39
Price/Tangible Book Value Low	- -	- -	3.54	1.79	2.52	2.79	2.57
Price/Sales	- -	- -	214.72	34.11	46.71	31.69	24.65
Price/Sales Average	- -	- -	317.13	41.24	37.96	39.4	33.63
Price/Sales High	- -	- -	536.62	80.64	79.33	73.79	74.48
Price/Sales Low	- -	- -	191.16	21.76	21.51	26.25	22.84
Price/Cash Flow	- -	- -	-13.54	-16.2	-7.12	-5.16	-4.92
Price/Cash Flow Average	- -	- -	-19.99	-19.59	-5.79	-6.42	-6.72
Price/Cash Flow High	- -	- -	-33.83	-38.31	-12.09	-12.02	-14.87
Price/Cash Flow Low	- -	- -	-12.05	-10.34	-3.28	-4.28	-4.56
Price/Free Cash Flow Average	- -	- -	-26.69	-35.44	-6.05	-6.74	-6.88
Price/Free Cash Flow High	- -	- -	-45.16	-69.32	-12.65	-12.62	-15.23
Price/Free Cash Flow Low	- -	- -	-16.09	-18.71	-3.43	-4.49	-4.67
EV/Sales Average	- -	- -	289.77	28.66	30.19	31.09	24.67
EV/Sales High	- -	- -	509.25	68.07	71.56	65.49	65.52
EV/Sales Low	- -	- -	163.79	9.19	13.74	17.95	13.88
EV/EBITDA Average	0.9	3.06	-16.62	-4.86	-4.07	-4.11	-3.24
EV/EBITDA High	0.9	3.06	-29.21	-11.54	-9.64	-8.66	-8.62
EV/EBITDA Low	0.9	3.06	-9.39	-1.56	-1.85	-2.37	-1.83
EV/EBIT Average	0.86	2.91	-15.85	-4.63	-3.78	-3.8	-2.83
EV/EBIT High	0.86	2.91	-27.86	-10.99	-8.97	-8	-7.51
EV/EBIT Low	0.86	2.91	-8.96	-1.48	-1.72	-2.19	-1.59
Last Price	- -	- -	17.13	7.71	9.86	6.76	4.09
High Price	- -	- -	42.81	18.23	16.74	15.74	12.36
Enterprise Value Average	-54	-246	2,898	1,137	1,325	1,819	1,832
Enterprise Value High	-54	-246	5,093	2,701	3,140	3,830	4,865
Enterprise Value Low	-54	-246	1,638	365	603	1,050	1,030

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	156	156	170	191	234	397	528
Diluted Weighted Avg Shares	112	112	125	176	208	274	447
Basic Weighted Avg Shares	112	112	125	176	208	274	447
Revenue per Share	0.02	0.03	0.08	0.23	0.21	0.21	0.17
EBITDA per Share	-0.53	-0.72	-1.39	-1.33	-1.57	-1.61	-1.26
Operating Income per Share	-0.56	-0.75	-1.46	-1.4	-1.68	-1.75	-1.45
Basic EPS, GAAP	-0.55	-0.77	-1.49	-1.36	-1.58	-1.69	-1.44
Basic EPS from Cont Ops	-0.55	-0.77	-1.49	-1.36	-1.58	-1.69	-1.44
Diluted EPS, GAAP	-0.55	-0.77	-1.49	-1.36	-1.58	-1.69	-1.44
Diluted EPS from Cont Ops	-0.55	-0.77	-1.49	-1.36	-1.58	-1.69	-1.44
Dividend per Share	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.51	-0.4	-1.27	-0.48	-1.38	-1.31	-0.83
Free Cash Flow per Basic Share	-0.54	-0.46	-1.58	-0.69	-1.44	-1.37	-0.85
Cash & Equivalents per Share	0.62	2.33	4.12	3.13	1.88	2.17	1.66
Book Value per Share	-1.13	-1.9	-3.19	-3.64	-4.66	-5.22	-4.64
Tangible Book Value per Share	-1.1	-1.86	4.31	2.76	1.8	2.01	1.47

Recursion Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)